| Authors: |
Stolley DL; Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center., Casasent AK; Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center., Gamal BT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center., Basi A; Department of Leukemia, The University of Texas MD Anderson Cancer Center., Gui X; Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center., Gomez JA; Department of Leukemia, The University of Texas MD Anderson Cancer Center., Cho S; Department of Melanoma Medical Oncology Research, The University of Texas MD Anderson Cancer Center., Rocha L; Department of Veterinary Medicine & Surgery, The University of Texas MD Anderson Cancer Center., Li V; Department of Veterinary Medicine & Surgery, The University of Texas MD Anderson Cancer Center., Huynh T; Department of Veterinary Medicine & Surgery, The University of Texas MD Anderson Cancer Center., Ferri-Borgogno S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center., Burks JK; Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center; jburks@mdanderson.org. |
